(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 38.26% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Clearpoint Neuro's revenue in 2024 is $23,955,000.On average, 2 Wall Street analysts forecast CLPT's revenue for 2024 to be $844,088,083, with the lowest CLPT revenue forecast at $838,423,062, and the highest CLPT revenue forecast at $849,753,104. On average, 2 Wall Street analysts forecast CLPT's revenue for 2025 to be $1,280,024,913, with the lowest CLPT revenue forecast at $1,213,933,005, and the highest CLPT revenue forecast at $1,346,116,821.
In 2026, CLPT is forecast to generate $1,559,229,504 in revenue, with the lowest revenue forecast at $1,559,229,504 and the highest revenue forecast at $1,559,229,504.